Mitochondrial medicine for neurodegenerative diseases
- 11 January 2010
- journal article
- review article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 42 (5) , 560-572
- https://doi.org/10.1016/j.biocel.2010.01.004
Abstract
No abstract availableKeywords
This publication has 99 references indexed in Scilit:
- Mitochondrial abnormalities in cybrid cell models of sporadic Alzheimer's disease worsen with passage in cultureNeurobiology of Disease, 2004
- Effects of Selected Ginsenosides on Phorbol Ester‐Induced Expression of Cyclooxygenase‐2 and Activation of NF‐κB and ERK1/2 in Mouse SkinAnnals of the New York Academy of Sciences, 2002
- Novel mitochondrial DNA mutations in Parkinson's diseaseJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 2002
- Further Evidence for Mitochondrial Dysfunction in Progressive Supranuclear PalsyExperimental Neurology, 2001
- Frontal Lobe Dysfunction in Progressive Supranuclear PalsyJournal of Neurochemistry, 2000
- Peptide nucleic acid delivery to human mitochondriaGene Therapy, 1999
- Cyclosporin A Increases Resting Mitochondrial Membrane Potential in SY5Y Cells and Reverses the Depressed Mitochondrial Membrane Potential of Alzheimer's Disease CybridsBiochemical and Biophysical Research Communications, 1998
- Mitochondrial DNA Mutations in Alzheimer's DiseaseBiochemical and Biophysical Research Communications, 1997
- Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: a model of familial amyotrophic lateral sclerosis (FALS)Brain Research, 1995
- A pilot trial of high-dose alpha-tocopherol and ascorbate in early Parkinson's diseaseAnnals of Neurology, 1992